Delayed Radioprotection by Thiols
Delayed Radioprotection by Thiols
批准号:
7059411
负责人:
DAVID J. GRDINA
金额:
$29.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
antioxidantscatalasecell proliferationenzyme activityflow cytometrygene expressionglutathione peroxidasehydrogen peroxideimmunoprecipitationlaboratory mouseneoplasm /cancer radiation therapyneoplastic growthnuclear factor kappa betaperoxynitritesradiation dosageradiation sensitivityradioprotective agentssuperoxide dismutasethiolstissue /cell culturewestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this investigation is the characterization of the delayed radioprotective effect induced following exposure of cells to non-protein thiols (NPT). The underlying hypothesis is that NPT exposure of cells results in activation of the redox sensitive nuclear transcription factor kappaB (NFkappaB) and enhancement in manganese superoxide dismutase (MnSOD) gene expression followed by elevated intracellular levels of active MnSOD protein. MnSOD is an anti-oxidant protein that can confer protection against oxidative radical species induced by ionizing radiation. The ability of NPT to induce at a later time elevated MnSOD levels results in a delayed radioprotective effect that will have implications in radioprotection in general, and tumor protection in particular. This study focuses on four clinically approved NPT, amifostine, mesna, Nacetylcysteine (NAC), and captopril. These NPT are currently in clinical use, and the potential for their induction of a delayed radioprotective effect in tumors of patients undergoing cancer treatment is a here-tofore unrecognized problem. Four specific aims are proposed. Aim 1 seeks to test the hypothesis that NPT over a range of doses will enhance MnSOD gene expression, leading to elevated intracellular levels of active MnSOD protein accompanied by increased catalase and glutathione peroxidase (GPx) activities in cultured tumor and non-tumor cells. Aim 2 will test the hypothesis that elevated MnSOD activity will result in enhanced radioprotection, especially at 2 Gy. Aim 3 is focused on testing the hypothesis that either single or multiple exposures of animals to NPT will result in elevated MnSOD gene expression and protein activity in both normal and tumor tissues, the latter grown as pulmonary tumor nodules or solid tumors in the hind legs of animals. Aim 4 will test the hypothesis that elevated MnSOD activity will result in delayed radioprotection to selected normal and tumor tissues as determined by quantitative survival assays, i.e., spleen colony assay, intestinal microcolony assay, lung colony assay, and the TCD50 assay. Two alternative hypotheses will also be tested. One elevated MnSOD activity can result in anti-oxidant imbalance relating to catalase and GPx activities, resulting in hydrogen peroxide buildup and radiation sensitization. Two, elevation in MnSOD level without a concomitant increase in enzymatic activity can result from nitration of MnSOD by peroxynitrite (ONOO-).
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response.
氨磷汀可在正常组织和可移植肿瘤中诱导抗氧化酶活性,从而影响放射反应。
DOI:
10.1016/j.ijrobp.2008.10.061
发表时间:
2009-03-01
期刊:
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
影响因子:
7
作者:
[Grdina, David J., Murley, Jeffrey S., Kataoka, Yasushi, Baker, Kenneth L., Kunnavakkam, Rangesh, Coleman, Mitchell C., Spitz, Douglas R.]
通讯作者:
Spitz, Douglas R.
Radiation Protectors and Radiation Therapy Coupled Chemoprevention
-
批准号:8070528
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2009
-
负责人:DAVID J. GRDINA
-
依托单位:
Radiation Protectors and Radiation Therapy Coupled Chemoprevention
-
批准号:8245173
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2009
-
负责人:DAVID J. GRDINA
-
依托单位:
Radiation Protectors and Radiation Therapy Coupled Chemoprevention
-
批准号:8450913
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2009
-
负责人:DAVID J. GRDINA
-
依托单位:
Radiation Protectors and Radiation Therapy Coupled Chemoprevention
-
批准号:7728207
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2009
-
负责人:DAVID J. GRDINA
-
依托单位:
Radiation Protectors and Radiation Therapy Coupled Chemoprevention
-
批准号:7846235
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2009
-
负责人:DAVID J. GRDINA
-
依托单位:
Delayed Radioprotection by Thiols
-
批准号:6895430
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:DAVID J. GRDINA
-
依托单位:
Delayed Radioprotection by Thiols
-
批准号:6678017
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:DAVID J. GRDINA
-
依托单位:
Delayed Radioprotection by Thiols
-
批准号:6765096
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6397829
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2000
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6396736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6395595
-
项目类别:
-
资助金额:$10.11万
-
财政年份:1999
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6101634
-
项目类别:
-
资助金额:$10.11万
-
财政年份:1998
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6268775
-
项目类别:
-
资助金额:$10.11万
-
财政年份:1998
-
负责人:DAVID J. GRDINA
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:6236178
-
项目类别:
-
资助金额:$10.51万
-
财政年份:1997
-
负责人:DAVID J. GRDINA
-
依托单位:
EXPERIMENTAL RADIOTHERAPY--CARCINOGENESIS, AND PROTECTOR
-
批准号:6512484
-
项目类别:
-
资助金额:$26.44万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
EXPERIMENTAL RADIOTHERAPY, CARCINOGENSIS, AND PROTECTORS
-
批准号:2007455
-
项目类别:
-
资助金额:$34.88万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
EXPERIMENTAL RADIOTHERAPY, CARCINOGENESIS, AND PROTECTOR
-
批准号:3175279
-
项目类别:
-
资助金额:$20.25万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
EXPERIMENTAL RADIOTHERAPY, CARCINOGENESIS, AND PROTECTOR
-
批准号:3175287
-
项目类别:
-
资助金额:$30.48万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
"EXPERIMENTAL RADIOTHERAPY, AND PROTECTORS"
-
批准号:3175282
-
项目类别:
-
资助金额:$13.1万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
EXPERIMENTAL RADIOTHERAPY--CARCINOGENESIS, AND PROTECTOR
-
批准号:6632932
-
项目类别:
-
资助金额:$26.41万
-
财政年份:1983
-
负责人:DAVID J. GRDINA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
木薯CC类谷氧还蛋白MeGRXC3修饰Catalase1蛋白调控过氧化氢酶活性的分子机制
-
批准号:32360458
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2023
-
负责人:郭鑫
-
依托单位:
Catalase调控滑膜巨噬细胞NLRP3炎症小体/Caspase-1/IL-1β轴修复骨关节炎软骨损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:李斯明
-
依托单位:
转录因子(FOXO3a)对心肌细胞衰老调控的分子机理研究
-
批准号:30973151
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2009
-
负责人:谭薇琦
-
依托单位:
视神经炎的多基因治疗研究
-
批准号:30471847
-
项目类别:面上项目
-
资助金额:21.0万元
-
批准年份:2004
-
负责人:顾欣祖
-
依托单位: